User:Samuel Veince/sandbox/McArthur

Justin C. McArthur, MBBS, MPH, is an American neurologist. He holds the John W. Griffin Professorship and serves as the Director of Neurology at the Johns Hopkins University School of Medicine. He also holds the position of neurologist-in-chief at The Johns Hopkins Hospital. Additionally, he leads the Sheikh Khalifa Stroke Institute at Johns Hopkins Hospital.

McArthur is the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for Novel Therapeutics of HIV-associated Cognitive Disorders. He is an elected member of the National Academy of Medicine.

Education
McArthur earned his medical degree from Guy's Hospital Medical School in London, UK. He completed his residency in internal medicine and neurology at The Johns Hopkins Hospital, where he also obtained his master’s in public health.

Career
McArthur leads the Johns Hopkins/National Institute of Mental Health Research Center for Novel Therapeutics of HIV-associated Cognitive Disorders. The center aims to translate pathophysiological discoveries into practical treatments for HIV-associated dementia (HIV-D).

Since 2008, McArthur has held the position of Director of the Department of Neurology at Johns Hopkins University. He also holds the John W. Griffin Professorship in neurology.

In 2013, McArthur was honored with the American Academy of Neurology’s Mitchell B. Max Award for Neuropathic Pain. In April 2017, McArthur was elected to the Association of American Physicians, recognizing his contributions to medical science.

In 2019, McArthur became president of the American Neurological Association. He was elected to the National Academy of Medicine (NAM) in 2020.

Reserach work
He has made significant strides in the study of HIV infection, multiple sclerosis, and related neurological disorders. His research spans three critical areas related to HIV-associated neurological manifestations Neuroepidemiology, therapeutic development, Clinical Trials and pathogenesis studies

McArthur's work significantly impacts both clinical practice and scientific understanding in the field of neurology. He developed a technique that utilizes tiny skin biopsies to assess nerve damage. This method is particularly valuable for individuals with diabetes, HIV, or those who have undergone chemotherapy.